Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2019 12:53 ET | Source: CTD Holdings, Inc.

CTD Holdings Submits Application for Listing on NASDAQ

ALACHUA, FL, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the...
February 28, 2019 10:00 ET | Source: CTD Holdings, Inc.

CTD Holdings Announces Grant to U.S. Non-Profit Organization to Support Patient Participation in Informational Meetings with Regulators

Support is part of CTD’s efforts to recognize Rare Disease Day 2019 ALACHUA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that...
February 15, 2019 10:04 ET | Source: CTD Holdings, Inc.

CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer

ALACHUA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
February 07, 2019 08:00 ET | Source: CTD Holdings, Inc.

CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick Disease Type C

ALACHUA, Fla., Feb. 07, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
January 18, 2019 08:00 ET | Source: CTD Holdings, Inc.

CTD Announces Partnership with United BioSource LLC (UBC) to support the Extension Protocol for its Phase I Clinical Trial in the United States

ALACHUA, Fla., Jan. 18, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
January 10, 2019 08:00 ET | Source: CTD Holdings, Inc.

CTD Announces Presentation at Upcoming Conference on Lysosomal Storage Diseases

Annual conference offers opportunities for academic researchers and industry representatives to exchange information on novel therapeutic interventions ALACHUA, Fla., Jan. 10, 2019 (GLOBE NEWSWIRE)...
January 08, 2019 08:52 ET | Source: CTD Holdings, Inc.

CTD Holdings’ Senior VP for Medical Affairs Appointed to Committee of the National Academies of Sciences, Engineering, and Medicine

ALACHUA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
December 21, 2018 08:00 ET | Source: CTD Holdings, Inc.

CTD Holdings Closes $2.0 Million Private Placement

ALACHUA, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
December 12, 2018 08:00 ET | Source: CTD Holdings, Inc.

CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases

ALACHUA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
December 10, 2018 09:11 ET | Source: CTD Holdings, Inc.

CTD Holdings to Present at Brains for Brain Conference on Lysosomal Storage Diseases

ALACHUA, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...

Next Page keyboard_arrow_right